Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BYON4413 |
Trade Name | |
Synonyms | BYON-4413|BYON 4413 |
Drug Descriptions |
BYON4413 is an antibody-drug conjugate (ADC) targeting IL3RA (CD123), which potentially decreases tumor growth (Blood (2023) 142 (Supplement 1): 2795). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Azacitidine + BYON4413 + Venetoclax | Azacitidine BYON4413 Venetoclax | 0 | 0 |
BYON4413 | BYON4413 | 0 | 1 |